| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |